# Shaping the Future of NMSC

> Education

Canonical page: [https://chrome-stats.com/d/id6746297272](https://chrome-stats.com/d/id6746297272)

## Overview

- **ID:** `id6746297272`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** Med Learning Group
- **Category:** Education
- **Version:** 1.1.1
- **Last updated:** 2025-10-02
- **First published:** 2025-05-24
- **Size:** 297 MB
- **Data as of:** 2026-09-07
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/shaping-the-future-of-nmsc/id6746297272)
- **Privacy policy:** [http://www.medlearninggroup.com/privacy-policy/](http://www.medlearninggroup.com/privacy-policy/)

## Description

Non-melanoma skin cancers (NMSCs), including basal cell carcinoma and cutaneous squamous cell carcinoma, are typically managed with Mohs micrographic surgery, but advanced cases may require alternative approaches due to inoperability or progression. The immunogenicity of NMSCs makes them strong candidates for immune checkpoint inhibitor therapy, with agents like cemiplimab and pembrolizumab demonstrating favorable efficacy and tolerability. Emerging strategies, including neoadjuvant and intralesional immunotherapy, are under investigation to enhance tumor response prior to or in place of surgery. Continued development of these immunotherapeutic approaches offers the potential to improve outcomes in patient care.

## Rankings

- #1,317,391 — Overall

## Similar extensions and apps

- [NMSC Immunotherapy Guide IAR](https://chrome-stats.com/d/id6771424147)
- [Squamous Cell Cancer-Head/Neck](https://chrome-stats.com/d/id1587934843)
- [Mohs Appropriate Use Criteria](https://chrome-stats.com/d/id692790649) — 5.00 / 5
- [Myeloma BsAb iAR](https://chrome-stats.com/d/id6755856552)
- [Multiple Myeloma Management](https://chrome-stats.com/d/id6449560414)
- [DART IGSRT](https://chrome-stats.com/d/id6761265922) — 5.00 / 5
- [Non-Small-Cell Lung Cancer](https://chrome-stats.com/d/id1578560593)
- [Nevus AI](https://chrome-stats.com/d/id6502666699) — 3.50 / 5
- [Oncology Cases: ASCCP Practice](https://chrome-stats.com/d/id6758357231)
- [My Melanoma apP](https://chrome-stats.com/d/id1087089652)
- [Hollings Clinical Trials](https://chrome-stats.com/d/id1612672405) — 5.00 / 5
- [Skin Cancer Tracker](https://chrome-stats.com/d/id6482296768) — 5.00 / 5

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id6746297272)